Aspirin's potential role in dementia risk reduction
A recent study conducted by Monash University shows that taking low doses of aspirin can reduce the risk of developing dementia by approximately 70% in older adults who carry genetic traits associated with platelet count. The study found that only 1% of these participants who took aspirin developed dementia, compared to 3.3% of those who took a placebo. However, aspirin use was associated with an increased risk of severe bleeding, as 4.4% of users experienced bleeding events compared to 2.1% of those on placebo. The results emphasize that the effects of aspirin may vary depending on genetic characteristics, opening the door for future studies to test its effectiveness in preventing dementia among specific genetic groups, with the important advice to consult a doctor before using it.
Notice: This Is an AI-Generated Summary
Comments (0)